Publications by the researcher in collaboration with Juan Jesús Cruz Hernández (8)

2024

  1. Epidemiología del cáncer. Factores de riesgo y carcinogénesis

    Oncología clínica (Arán), pp. 25-42

2022

  1. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  2. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2017

  1. Epidemiología del cáncer. Factores de riesgo y carcinogénesis

    Oncología Clínica (Elsevier España), pp. 13-24

  2. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

    Breast Journal, Vol. 23, Núm. 6, pp. 745-746

2011

  1. Pacientes con criterios clínicos de síndrome de Lynch con y sin mutación en genes reparadores del ADN (MLH1 y MSH2). Un reto para el clínico

    Medicina Clinica, Vol. 137, Núm. 4, pp. 166-170

2005

  1. Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer

    Anti-Cancer Drugs, Vol. 16, Núm. 1, pp. 77-82

2002

  1. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma [1] (multiple letters)

    Cancer